DFFVX
Price
$36.79
Change
+$0.08 (+0.22%)
Updated
Sep 5 closing price
Net Assets
13.95B
MVSSX
Price
$32.84
Change
+$0.51 (+1.58%)
Updated
Sep 4 closing price
Net Assets
1.07B
Interact to see
Advertisement

DFFVX vs MVSSX

Header iconDFFVX vs MVSSX Comparison
Open Charts DFFVX vs MVSSXBanner chart's image
DFA US Targeted Value I
Price$36.79
Change+$0.08 (+0.22%)
VolumeN/A
Net Assets13.95B
Victory Integrity Small-Cap Value R6
Price$32.84
Change+$0.51 (+1.58%)
VolumeN/A
Net Assets1.07B
DFFVX vs MVSSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFFVX vs. MVSSX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and MVSSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.9B vs. MVSSX (1.07B). MVSSX pays higher dividends than DFFVX: MVSSX (1.64) vs DFFVX (1.50). DFFVX was incepted earlier than MVSSX: DFFVX (26 years) vs MVSSX (13 years). MVSSX (0.96) is less costly to investors than DFFVX (0.30). MVSSX is a more actively managed with annual turnover of: 62.00 vs. DFFVX (7.00). DFFVX (0) and MVSSX (0) have matching initial minimum investment requirements. DFFVX annual gain was more profitable for investors over the last year : 13.85 vs. MVSSX (-7.38). DFFVX return over 5 years is better than : 105.61 vs. MVSSX (24.52).
DFFVXMVSSXDFFVX / MVSSX
Total Expense Ratio0.290.9630%
Annual Report Gross Expense Ratio0.300.9631%
Fund Existence26 years13 years-
Gain YTD8.0274.373184%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets13.9B1.07B1,299%
Annual Yield % from dividends1.501.6491%
Returns for 1 year13.85-7.38-188%
Returns for 3 years40.17-3.64-1,104%
Returns for 5 years105.6124.52431%
Returns for 10 years83.268.63964%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOAR76.482.75
+3.73%
Loar Holdings
GLUE4.940.03
+0.61%
Monte Rosa Therapeutics
JANX23.980.04
+0.17%
Janux Therapeutics
JPM294.38-9.44
-3.11%
JPMorgan Chase & Co
RENB0.21-0.01
-3.23%
Renovaro